Rheumacare capsules recalled after being found to contain lead
Rheumacare capsules manufactured by Virgo UAP Pharma in India were found to contain lead due to manufacturing defects. The affected product is a 30-count bottle with lot numbers CAM040 (expires 06/30/2029) or CAL079-N (expires 09/30/2028). Only 4 bottles were distributed to a customer in New York.
From the FDA notice · Read the official notice ↗
What to do
- Stop taking Rheumacare capsules immediately if you have lot CAM040 or CAL079-N
- Contact your doctor or pharmacist if you have taken this product
- Return unused capsules to the pharmacy where purchased
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
- UPC code
- 8904218700313
- Sold in
- Product was distributed to one customer in NY.
- Made for
- Adults (0 months and older)
Details
- Units affected
- 4 bottles /30 capsules each
- Illnesses reported
- None reported
- Manufactured in
- South Plainfield, 4300 S Clinton Ave, South Plainfield, NJ, United States
- Classification
- Class I
- Recall number
- D-0332-2026
In the FDA's words
- Description
- Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 CGMP Deviations: product found to contain lead. Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028 Distribution: Product was distributed to one customer in NY. Affected quantity: 4 bottles /30 capsules each
- Hazard
- CGMP Deviations: product found to contain lead.